- Home
- NEUP vs ICU Comparison
NEUP vs ICU Comparison
Compare NEUP & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- ICU
- Stock Information
- Founded
- NEUP 1996
- ICU 2018
- Country
- NEUP United States
- ICU United States
- Employees
- NEUP N/A
- ICU N/A
- Industry
- NEUP
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- NEUP
- ICU Health Care
- Exchange
- NEUP Nasdaq
- ICU Nasdaq
- Market Cap
- NEUP 12.7M
- ICU 10.4M
- IPO Year
- NEUP N/A
- ICU N/A
- Fundamental
- Price
- NEUP $7.01
- ICU $0.42
- Analyst Decision
- NEUP Strong Buy
- ICU
- Analyst Count
- NEUP 1
- ICU 0
- Target Price
- NEUP $21.00
- ICU N/A
- AVG Volume (30 Days)
- NEUP 22.3K
- ICU 15.9M
- Earning Date
- NEUP 08-15-2025
- ICU 08-12-2025
- Dividend Yield
- NEUP N/A
- ICU N/A
- EPS Growth
- NEUP N/A
- ICU N/A
- EPS
- NEUP 0.00
- ICU N/A
- Revenue
- NEUP $15,662,715.00
- ICU $428,000.00
- Revenue This Year
- NEUP N/A
- ICU $754.07
- Revenue Next Year
- NEUP N/A
- ICU $100.09
- P/E Ratio
- NEUP $4,149.50
- ICU N/A
- Revenue Growth
- NEUP N/A
- ICU N/A
- 52 Week Low
- NEUP $2.90
- ICU $0.31
- 52 Week High
- NEUP $126.00
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- ICU 18.81
- Support Level
- NEUP N/A
- ICU $0.31
- Resistance Level
- NEUP N/A
- ICU $0.67
- Average True Range (ATR)
- NEUP 0.00
- ICU 0.12
- MACD
- NEUP 0.00
- ICU -0.08
- Stochastic Oscillator
- NEUP 0.00
- ICU 11.55
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.